| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
23,437,500 |
shares |
6.5% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$319,103 |
USD |
-94% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$235,086 |
USD |
102% |
Q3 2025 |
Q2 2026 |
| Operating Lease, Liability |
$420,354 |
USD |
101% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$457,992 |
USD |
105% |
Q3 2025 |
Q2 2026 |
| Operating Lease, Liability, Current |
$134,994 |
USD |
48% |
Q3 2025 |
Q2 2026 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.0431 |
pure |
-2.5% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$37,638 |
USD |
162% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$94,932 |
USD |
|
Q3 2025 |
Q2 2026 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q2 2026 |
| Additional Paid in Capital |
$10,420,096 |
USD |
95% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$235,086 |
USD |
102% |
Q3 2025 |
Q2 2026 |